Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-02 Sale |
2024-12-04 4:06 pm |
BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner |
17,842,500 | $200 | $3,568,500,000 | 125,045,741 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-14 Exercise |
2025-04-16 5:12 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 11,146,145 (Direct) |
View |
| 2025-04-14 Exercise |
2025-04-16 5:12 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 11,146,145 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
16,477 | $119.96 | 1,488,482 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:04 pm |
N/A 2029-06-04 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
674,973 | $0 | 1,488,482 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:04 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
35,444 | $174.43 | 1,488,482 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:53 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 11,689,025 (Direct) |
View |
| 2025-03-18 Exercise |
2025-03-20 4:53 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 11,689,025 (Direct) |
View |
| 2025-03-11 Gift |
2025-03-13 4:43 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
158,717 | $0 | 10,060,378 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 5:02 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,033,552 | $0 | 50,110,738 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
41,210 | $6.5 | 50,110,738 (Direct) |
View |
| 2025-03-10 Exercise |
2025-03-12 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
497,822 | $0.5 | 50,110,738 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-07 8:17 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,470,417 | $0 | 51,144,290 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-07 8:17 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
58,590 | $6.5 | 51,144,290 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-07 8:17 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
708,747 | $0.5 | 51,144,290 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-07 7:26 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,007,578 | $0 | 52,614,707 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-07 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
40,109 | $6.5 | 52,614,707 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
201,084 | $0 | 52,614,707 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-07 7:26 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
486,161 | $0.5 | 52,614,707 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 7:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
44,873 | $119.96 | 230,568 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 7:24 pm |
N/A 2028-04-29 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
674,973 | $0 | 230,568 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 7:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
7,048 | $169.65 | 230,568 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:24 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
103,883 | $0 | 230,568 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:22 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
69,251 | $0 | 1,722,136 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:20 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel |
40,209 | $0 | 246,142 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 7:19 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Rosenberg Aaron Chief Financial Officer |
48,581 | $0 | 167,128 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:59 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
2,533,531 | $0 | 53,627,732 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:59 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
101,000 | $6.5 | 53,627,732 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:59 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,220,531 | $0.5 | 53,627,732 (Direct) |
View |
| 2025-02-18 Exercise |
2025-02-20 6:12 pm |
N/A 2028-04-29 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
674,973 | $0 | 1,547,415 (Direct) |
View |
| 2025-02-18 Exercise |
2025-02-20 6:12 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
51,921 | $169.65 | 1,547,415 (Direct) |
View |
| 2025-02-04 Exercise |
2025-02-06 4:44 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 12,496,520 (Direct) |
View |
| 2025-02-04 Exercise |
2025-02-06 4:44 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 12,496,520 (Direct) |
View |
| 2025-01-07 Exercise |
2025-01-08 5:08 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 13,039,400 (Direct) |
View |
| 2025-01-07 Exercise |
2025-01-08 5:08 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 13,039,400 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 5:02 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,300,000 | $0 | 59,140,096 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 5:02 pm |
N/A N/A |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,300,000 | $0.5 | 59,140,096 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 5:18 pm |
N/A 2025-07-19 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
542,880 | $0 | 13,582,280 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 5:18 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
41,760 | $6.5 | 13,582,280 (Direct) |
View |
| 2024-11-26 Exercise |
2024-11-29 4:31 pm |
N/A 2025-06-29 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
499,993 | $0 | 10,325,000 (Direct) |
View |
| 2024-11-26 Exercise |
2024-11-29 4:31 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
38,461 | $6.5 | 10,325,000 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-02 7:21 pm |
N/A 2034-09-29 |
BeiGene Ltd. | BGNE | Sharp Shalini Director |
25,389 | $0 | 25,389 (Direct) |
View |
| 2024-08-12 Gift |
2024-08-14 5:27 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
301,457 | $0 | 10,453,563 (Direct) |
View |
| 2024-08-09 Option Award |
2024-08-13 5:17 pm |
N/A 2034-08-08 |
BeiGene Ltd. | BGNE | Rosenberg Aaron Chief Financial Officer |
339,534 | $0 | 339,534 (Direct) |
View |